60
Participants
Start Date
July 27, 2018
Primary Completion Date
May 9, 2021
Study Completion Date
May 9, 2021
Transdermal Estradiol + Placebo
.1mg/24hr transdermal estradiol for 14 days starting day 7 after positive urine luteinizing hormone test, plus twice daily placebo pills during the same time frame.
Oral Micronized Progesterone + Placebo
100mg oral micronized progesterone twice daily for 14 days starting day 7 after positive urine luteinizing hormone test, plus weekly application of a placebo patch during the same time frame.
Placebos
Twice daily placebo pills for 14 days starting day 7 after positive urine luteinizing hormone test, plus weekly application of a placebo patch during the same time frame.
University of Illinois Neuropsychiatric Institute, Chicago
National Institute of Mental Health (NIMH)
NIH
University of Illinois at Chicago
OTHER